Radiation Oncologist at Dana Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School. Focus on prostate cancer and MRI guided radiation.
Boston, MA
Joined December 2019
- Tweets48
- Following152
- Followers190
- Likes245
Jonathan Leeman retweeted
May is #BladderCancerAwarenessMonth. We're highlighting studies in our GU portfolio. NRG-GU015 The ARCHER Study is enrolling patients with cT2-cT3 MIBC that is clinically node negative. Learn more ➡️ ow.ly/RqQm50YZJ59 @UroCancer @HimanshuNagarMD
Jonathan Leeman retweeted
A novel master clinical trial applied to stereotactic MRI guided adaptive radiotherapy (SMART) demonstrates low rates of toxicity and highlights the benefits of the master protocol approach: oxford.ly/3XuGEGr @jonathan_leeman
Jonathan Leeman retweeted
🔔Education Opportunity for Patients with #ProstateCancer & Their Families
📆 5/17/24 8amEST (virtual)
Here from experts discussing
✴️ Diet/Lifestyle 🚴♂️
✴️ AI 🤖
✴️ Biochemical Recurrence 📈
✴️ Genetics 🧬
✴️ Survivorship ☺️
Register for FREE! ✍🏽
Link: shorturl.at/ehjx8
Jonathan Leeman retweeted
🔬 Congrats to @LeeGraceMD & our MR-guided #RT team @BrighamWomens /@DanaFarber for our study on 5-fx stereotactic #MRI-guided adaptive #Radiotherapy for high-risk thoracic oligo-mets (19 ultra+7 central), now out in @RadiotherapyOn1. #Cancer #LCSM #radonc sciencedirect.com/science/ar…
Jonathan Leeman retweeted
Our top 5 articles from the week, with: @AlexSpiraMDPhD @JSabari @DasMillie11 @MNagasaka @tarasanftmd @jonathan_leeman
1. bit.ly/3PiEGV3
2. bit.ly/3PlPZvL
3. bit.ly/3sVwMJN
4. bit.ly/3LrQQdk
5. bit.ly/3LlCvif
Jonathan Leeman retweeted
Exciting news! We're hiring for a new Director of GU Radiation Oncology @MSKCancerCenter. Big shoes to fill,but an awesome opportunity to run a large service with a lot of active research, trials,and technology. #radonc @MSK_RadOnc @ASTRO_org #medtwitter
externaltalent-mskcc.icims.c…
Jonathan Leeman retweeted
1/ Check out this preprint that describes how we developed and validated a new #AI-based biomarker that we are calling “FaceAge”, which uses a simple face #photo to predict outcomes in #cancer patients!
medrxiv.org/content/10.1101/…
#oncology #AImedicine #FaceAge
Jonathan Leeman retweeted
🌟 @HElhalawaniMD and Dr Veena Venkatachalam treated 11 yr old Celeste with novel MR-LINAC
bwhbulletin.org/2023/08/24/r…
Jonathan Leeman retweeted
In a new @JAMANetworkOpen study, @BenjaminKannMD & @DanaFarber researchers developed an AI model to diagnose muscle wasting, known as sarcopenia, using CT scans in patients with head and neck cancer, aiding timely interventions.
Release here ➡️ ms.spr.ly/60149JXU8
Jonathan Leeman retweeted
Join us Sept. 22 for the X-Ray-Guided Online Adaptive Radiotherapy Symposium in Dallas! This symposium will provide a full day of presentations and interactive sessions with leading experts in adaptive radiotherapy.
For more info and registration: bit.ly/3OpfZHp
Jonathan Leeman retweeted
New in #ProstateCancer research | This meta-analysis of prostate SBRT studies found a significant reduction in the risk of acute urinary and GI side effects with MR-guided daily adaptive SBRT compared to standard CT-guided SBRT.
🔗acsjournals.onlinelibrary.wi…
@jonathan_leeman @BrighamRadOnc @OncoAlert @WalterStadler5 @WileyOnc_Hem
#PCSM
Jonathan Leeman retweeted
Happy to share our latest study. We validated our deep learning ENE algorithm in the context of the @eaonc E3311 HPV+OPC de-escalation trial.
Congratulations and a huge thank you all the co-authors for their help on this large, multi-institutional effort.
1/x
NEW Research on screening for extranodal extension in HPV-associated oropharyngeal #carcinoma using a CT-based #DeepLearning algorithm in a randomised de-escalation trial. @BenjaminKannMD
@BarbaraBurtness @RobertFerrisMD
Read it here: bit.ly/3KYvTpn
Jonathan Leeman retweeted
📢 CALL FOR PAPERS - We are inviting submissions to a collection on #cancer therapy #toxicity, guest edited by Drs. Raymond Mak (@Dr_RayMak), Miranda Fidler-Benaoudia (@MirandaFidlerB) & Lova Sun. Find out more: ow.ly/GGAK50Ngy5p
Jonathan Leeman retweeted
📢Pleased to announce the recipients of the inaugural
☢️Radiation Oncology Accelerator Awards 🥇🥇
intended to foster collaborations between @DanaFarber/@BrighamWomens & @MGHCancerCenter #radonc
Incredibly deserving group of early-stage investigators 🔥👏
#teamscience
Jonathan Leeman retweeted
🆕Does PSA at time of salvage therapy after radical prostatectomy for prostate cancer matter? Tilki, D'Amico, and co-authors report multinational findings here: pubmed.ncbi.nlm.nih.gov/3685…
Jonathan Leeman retweeted
Here is the latest: do we need to consider histologic subtype for NSCLC in #radonc ? An editorial with @maraantonoff and Dr. Annikka Weissferdt of @MDAndersonNews
authors.elsevier.com/a/1gdao…
HT @jonathan_leeman
#lcsm #tssmn
cc @ElliotServaisMD @BrendonStilesMD @JFreemanDaily
Jonathan Leeman retweeted
Abs#298 @ASCO #GU23 👉bit.ly/3E4TrX0: In pts with localized #prostatecancer (T1-T2; Gleason ≤ 3 + 4; PSA ≤ 20 ng/mL) ➡️ radiation (SBRT) associated with better urinary continence & sexual bother but more bowel bother after 2 yrs vs surgery @urotoday @PCFnews @Uromigos
Jonathan Leeman retweeted
I asked ChatGPT to give me 22 common regrets people have on their deathbeds
The results were eye-openers:
Jonathan Leeman retweeted
Pleased to share the primary endpoint results of the randomized phase III MIRAGE trial evaluating whether aggressive margin reduction with MRI-guidance leads to reduced toxicity in the context of prostate SBRT, out today in @JAMAOncology jamanetwork.com/journals/jam… (1/n)
